Fed. Circ. Clears Boston Scientific In $49M Stent Patent Case
The Federal Circuit on Monday overturned a $49.4 million patent judgment against Boston Scientific, ruling that the company's drug-eluting coronary stents did not infringe a patent owned by the University of...To view the full article, register now.
Already a subscriber? Click here to view full article